CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Cash Flow Y/Y Annual
Regencell Bioscience Holdings Limited  (NASDAQ: RGC)
 

RGC's Net Cash Flow Growth by Quarter and Year

Regencell Bioscience Holdings Limited's Net Cash Flow results by quarter and year

Download as CSV




RGC Net Cash Flow (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December -0.54 -4.85 6.36 -0.33
3rd Quarter September 0.00 0.00 0.00 0.00
2nd Quarter June 0.00 0.00 0.00 0.00
1st Quarter March 0.00 0.00 0.00 0.00
FY   -0.54 -4.85 6.36 -0.33

RGCs Annual Net Cash Flow
Regencell Bioscience Holdings Limited's Net Cash Flow in the fiscal year 2025 $ -0.54 millions
Regencell Bioscience Holdings Limited's Net Cash Flow in the fiscal year 2023 $ -4.85 millions
Regencell Bioscience Holdings Limited's Net Cash Flow in the fiscal year 2022 $ 0.00 millions
Regencell Bioscience Holdings Limited's Net Cash Flow in the fiscal year 2021 $ -0.33 millions
Regencell Bioscience Holdings Limited's Net Cash Flow in the fiscal year 2017 $ -17.70 millions




RGC Net Cash Flow fourth quarter 2025 Y/Y Growth Comment
Regencell Bioscience Holdings Limited in the fourth quarter 2025 recorded net cash outflow of $ -0.54 millions.

According to the results reported in the fourth quarter 2025, Regencell Bioscience Holdings Limited achieved the best Net Cash Flow growth in Legal Cannabis industry. While Regencell Bioscience Holdings Limited' s Net Cash Flow no change of 0% ranks overall at the positon no. in the fourth quarter 2025.


RGC Net Cash Flow ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   - - - -

Financial Statements
Regencell Bioscience Holdings Limited's fourth quarter 2025 Net Cash Flow $ -0.54 millions RGC's Income Statement
Regencell Bioscience Holdings Limited's fourth quarter 2024 Net Cash Flow $ -4.85 millions Quarterly RGC's Income Statement


RGC Net Cash Flow (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   - - - -


Go to RGC Cash flow Statement >> Back to RGC Growth rate Comparisons >>


Net Cash Flow fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Regencell Bioscience Holdings Limited's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RGC's IV. Quarter Q/Q Net Cash Flow Comment


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RGC's IV. Quarter Q/Q Net Cash Flow Comment


Regencell Bioscience Holdings Limited's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Jun 30 2025)		 12 Months Ending
(Jun 30 2023)		 12 Months Ending
0		 12 Months Ending
0		 12 Months Ending
0
Cumulative Net Cash Flow 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #


Cumulative Net Cash Flow growth Comment
In the Jun 30 2025 period, Regencell Bioscience Holdings Limited's cumulative trailing twelve month Net Cash Flow remained unchanged compare to the same period a year ago.

Regencell Bioscience Holdings Limited achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment
In the Jun 30 2025 period, Regencell Bioscience Holdings Limited's cumulative trailing twelve month Net Cash Flow remained unchanged compare to the same period a year ago.

Regencell Bioscience Holdings Limited achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Net Cash Flow Growth
Legal Cannabis Industry Net Cash Flow Growth Trends and Statistics
Consumer Non Cyclical Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
RGC's Net Cash Flow Growth Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth




Companies with similar Net Cash Flow no change for the quarter ending Jun 30 2025 within Consumer Non Cyclical SectorY/Y Change %Net Cash Flow for the quarter ending Jun 30 2025


About Regencell Bioscience Holdings Limited Net Cash Flow Growth Rates (RGC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.